CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 47.56
  • +0.96+2.06%
Not Open Nov 1 15:00 CST
303.39BMarket Cap55.69P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
18.67%20.19B
21.78%13.6B
9.20%6B
7.26%22.82B
6.70%17.01B
9.19%11.17B
0.25%5.49B
-17.87%21.28B
-21.06%15.95B
-23.08%10.23B
Operating revenue
18.67%20.19B
21.78%13.6B
9.20%6B
7.26%22.82B
6.70%17.01B
9.19%11.17B
0.25%5.49B
-17.87%21.28B
-21.06%15.95B
-23.08%10.23B
Other operating revenue
----
1,077.05%1.47B
----
611.05%442.6M
----
6,559.70%124.6M
----
-50.29%62.25M
----
-94.61%1.87M
Total operating cost
13.81%15.09B
11.77%9.76B
4.91%4.41B
2.63%18.21B
5.49%13.26B
9.27%8.73B
1.18%4.21B
-18.57%17.75B
-17.95%12.57B
-21.40%7.99B
Operating cost
6.61%2.83B
5.87%1.87B
9.70%942.85M
1.11%3.53B
-0.42%2.66B
4.83%1.77B
0.49%859.52M
-6.82%3.49B
-2.19%2.67B
-3.78%1.69B
Operating tax surcharges
5.95%172.41M
4.88%114.95M
13.86%58.02M
15.16%219.26M
13.07%162.73M
17.68%109.61M
0.68%50.95M
-5.66%190.39M
-8.27%143.92M
-12.02%93.14M
Operating expense
12.96%6.11B
7.06%3.94B
5.66%1.76B
3.12%7.58B
4.78%5.41B
12.61%3.68B
-5.05%1.67B
-21.70%7.35B
-26.22%5.16B
-29.98%3.27B
Administration expense
11.83%1.87B
8.31%1.17B
5.61%576.3M
4.79%2.42B
14.14%1.68B
10.98%1.08B
-2.43%545.67M
-19.36%2.31B
-4.57%1.47B
-16.09%976.71M
Financial expense
-20.58%-447.89M
-56.76%-382.22M
-117.50%-148.64M
-1.60%-478.39M
-0.12%-371.46M
-10.47%-243.82M
7.35%-68.34M
-39.33%-470.87M
-52.72%-371.03M
-106.76%-220.7M
-Interest expense (Financial expense)
-30.14%3.31M
-10.09%3.31M
----
-9.06%5.9M
130.68%4.74M
52.73%3.69M
-26.71%985.81K
37.82%6.49M
--2.06M
135.50%2.41M
-Interest Income (Financial expense)
-39.92%-490.92M
-77.97%-370.79M
-98.55%-166.46M
-23.84%-477.14M
-41.10%-350.86M
-24.25%-208.35M
9.48%-83.84M
-4.85%-385.28M
13.39%-248.67M
10.71%-167.69M
Research and development
22.10%4.55B
30.30%3.04B
6.21%1.22B
1.38%4.95B
6.52%3.73B
6.73%2.33B
14.05%1.15B
-17.78%4.89B
-15.56%3.5B
-15.36%2.18B
Credit Impairment Loss
-365.08%-14.29M
-330.24%-37.5M
-486.75%-12.98M
165.65%17.25M
82.97%-3.07M
141.12%16.29M
121.54%3.36M
-749.71%-26.28M
32.89%-18.04M
-12.90%-39.61M
Asset Impairment Loss
172.78%9.25M
--15.82M
--109.56K
26.91%-107.22M
---12.71M
----
----
-958.25%-146.68M
----
----
Other net revenue
31.90%245.97M
7.20%140.04M
-12.17%51.39M
-47.88%304.27M
-32.36%186.48M
-17.62%130.64M
31.86%58.51M
5.71%583.77M
42.90%275.7M
71.44%158.58M
Fair value change income
126.64%9.53M
127.30%7.54M
293.79%7.34M
-176.15%-58.26M
-2,111.84%-35.77M
-271.47%-27.62M
63.13%-3.79M
111.14%76.5M
96.46%-1.62M
254.47%16.11M
Invest income
-171.67%-31.42M
-68.86%-16.14M
-98.14%615.9K
-112.69%-49.16M
-110.77%-11.57M
-117.08%-9.56M
12.32%33.1M
81.49%387.36M
-36.09%107.41M
-45.20%55.98M
-Including: Investment income associates
-15.10%-54.23M
17.77%-34.38M
----
-15.40%-72.7M
---47.11M
---41.8M
----
-807.71%-63M
----
----
Asset deal income
-52.58%2.15M
-22.72%2.02M
26.53%1.62M
-42.22%3.16M
1,956.49%4.53M
665.72%2.61M
161.38%1.28M
62.36%5.47M
-92.81%220.44K
-120.18%-460.98K
Other revenue
10.48%270.74M
13.02%168.31M
122.67%54.68M
73.45%498.49M
30.54%245.07M
17.67%148.92M
-39.00%24.56M
-7.00%287.4M
99.03%187.73M
276.79%126.56M
Operating profit
35.62%5.35B
55.04%3.98B
21.69%1.64B
19.41%4.91B
7.93%3.94B
7.15%2.57B
-1.56%1.34B
-11.85%4.11B
-28.02%3.65B
-25.67%2.4B
Add:Non operating Income
137.84%5.79M
94.17%3.13M
-53.56%198.81K
82.46%3.8M
73.51%2.43M
70.07%1.61M
17.45%428.07K
-6.35%2.08M
-54.21%1.4M
-39.84%948.61K
Less:Non operating expense
101.19%264.34M
297.98%236.31M
564.84%133.7M
69.42%246.59M
10.18%131.39M
24.45%59.38M
2,876.16%20.11M
-27.49%145.55M
-19.04%119.24M
-52.78%47.71M
Total profit
33.43%5.09B
49.32%3.75B
13.42%1.5B
17.60%4.67B
7.88%3.81B
6.83%2.51B
-2.98%1.32B
-11.15%3.97B
-28.30%3.53B
-24.80%2.35B
Less:Income tax cost
30.18%470.41M
45.68%323.47M
47.80%135.02M
153.86%389.29M
-17.49%361.35M
-21.76%222.04M
-41.86%91.36M
965.50%153.35M
-40.57%437.95M
-39.00%283.8M
Net profit
33.77%4.62B
49.67%3.43B
10.87%1.37B
12.13%4.28B
11.47%3.45B
10.75%2.29B
2.08%1.23B
-14.92%3.82B
-26.14%3.1B
-22.32%2.07B
Net profit from continuing operation
33.77%4.62B
49.67%3.43B
10.87%1.37B
12.13%4.28B
11.47%3.45B
10.75%2.29B
2.08%1.23B
-14.92%3.82B
-26.14%3.1B
-22.32%2.07B
Less:Minority Profit
85.73%-3.25M
79.75%-3.62M
74.79%-1.44M
73.02%-24.62M
70.59%-22.75M
65.17%-17.86M
80.07%-5.72M
-97.51%-91.23M
-405.50%-77.34M
-886.91%-51.27M
Net profit of parent company owners
32.98%4.62B
48.67%3.43B
10.48%1.37B
10.14%4.3B
9.47%3.47B
8.91%2.31B
0.17%1.24B
-13.77%3.91B
-24.57%3.17B
-20.55%2.12B
Earning per share
Basic earning per share
32.73%0.73
50.00%0.54
10.53%0.21
11.48%0.68
10.00%0.55
9.09%0.36
0.00%0.19
-14.08%0.61
-24.24%0.5
-21.43%0.33
Diluted earning per share
32.73%0.73
50.00%0.54
10.53%0.21
11.48%0.68
10.00%0.55
9.09%0.36
0.00%0.19
-14.08%0.61
-24.24%0.5
-21.43%0.33
Other composite income
-190.19%-12.63M
-100.08%-17.23K
69.90%-5.93M
12.43%17.84M
311.21%14M
659.72%22.51M
-14,648.05%-19.69M
302.41%15.87M
-672.97%-6.63M
-1,273.58%-4.02M
Other composite income of parent company owners
-205.33%-11.5M
-104.12%-772.84K
66.49%-6.14M
8.96%16.09M
246.37%10.92M
505.91%18.74M
-72,524.52%-18.33M
300.53%14.77M
-948.39%-7.46M
-12,147.55%-4.62M
Other composite income of minority owners
-136.66%-1.13M
-79.95%755.61K
115.94%216.54K
59.17%1.75M
272.75%3.09M
532.90%3.77M
-1,155.38%-1.36M
331.60%1.1M
665.88%828.16K
333.43%595.53K
Total composite income
32.86%4.6B
48.22%3.43B
12.18%1.36B
12.13%4.3B
12.16%3.47B
12.06%2.31B
0.46%1.21B
-14.41%3.83B
-26.29%3.09B
-22.47%2.06B
Total composite income of parent company owners
32.24%4.61B
47.44%3.43B
11.63%1.36B
10.13%4.32B
10.07%3.48B
10.04%2.33B
-1.31%1.22B
-13.30%3.92B
-24.74%3.17B
-20.72%2.11B
Total composite income of minority owners
77.74%-4.38M
79.70%-2.86M
82.70%-1.22M
74.63%-22.87M
74.30%-19.66M
72.20%-14.09M
75.43%-7.07M
-93.16%-90.14M
-395.35%-76.52M
-829.79%-50.68M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Suya Jincheng Certified Public Accountants (Special General Partnership)
--
--
--
Suya Jincheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 18.67%20.19B21.78%13.6B9.20%6B7.26%22.82B6.70%17.01B9.19%11.17B0.25%5.49B-17.87%21.28B-21.06%15.95B-23.08%10.23B
Operating revenue 18.67%20.19B21.78%13.6B9.20%6B7.26%22.82B6.70%17.01B9.19%11.17B0.25%5.49B-17.87%21.28B-21.06%15.95B-23.08%10.23B
Other operating revenue ----1,077.05%1.47B----611.05%442.6M----6,559.70%124.6M-----50.29%62.25M-----94.61%1.87M
Total operating cost 13.81%15.09B11.77%9.76B4.91%4.41B2.63%18.21B5.49%13.26B9.27%8.73B1.18%4.21B-18.57%17.75B-17.95%12.57B-21.40%7.99B
Operating cost 6.61%2.83B5.87%1.87B9.70%942.85M1.11%3.53B-0.42%2.66B4.83%1.77B0.49%859.52M-6.82%3.49B-2.19%2.67B-3.78%1.69B
Operating tax surcharges 5.95%172.41M4.88%114.95M13.86%58.02M15.16%219.26M13.07%162.73M17.68%109.61M0.68%50.95M-5.66%190.39M-8.27%143.92M-12.02%93.14M
Operating expense 12.96%6.11B7.06%3.94B5.66%1.76B3.12%7.58B4.78%5.41B12.61%3.68B-5.05%1.67B-21.70%7.35B-26.22%5.16B-29.98%3.27B
Administration expense 11.83%1.87B8.31%1.17B5.61%576.3M4.79%2.42B14.14%1.68B10.98%1.08B-2.43%545.67M-19.36%2.31B-4.57%1.47B-16.09%976.71M
Financial expense -20.58%-447.89M-56.76%-382.22M-117.50%-148.64M-1.60%-478.39M-0.12%-371.46M-10.47%-243.82M7.35%-68.34M-39.33%-470.87M-52.72%-371.03M-106.76%-220.7M
-Interest expense (Financial expense) -30.14%3.31M-10.09%3.31M-----9.06%5.9M130.68%4.74M52.73%3.69M-26.71%985.81K37.82%6.49M--2.06M135.50%2.41M
-Interest Income (Financial expense) -39.92%-490.92M-77.97%-370.79M-98.55%-166.46M-23.84%-477.14M-41.10%-350.86M-24.25%-208.35M9.48%-83.84M-4.85%-385.28M13.39%-248.67M10.71%-167.69M
Research and development 22.10%4.55B30.30%3.04B6.21%1.22B1.38%4.95B6.52%3.73B6.73%2.33B14.05%1.15B-17.78%4.89B-15.56%3.5B-15.36%2.18B
Credit Impairment Loss -365.08%-14.29M-330.24%-37.5M-486.75%-12.98M165.65%17.25M82.97%-3.07M141.12%16.29M121.54%3.36M-749.71%-26.28M32.89%-18.04M-12.90%-39.61M
Asset Impairment Loss 172.78%9.25M--15.82M--109.56K26.91%-107.22M---12.71M---------958.25%-146.68M--------
Other net revenue 31.90%245.97M7.20%140.04M-12.17%51.39M-47.88%304.27M-32.36%186.48M-17.62%130.64M31.86%58.51M5.71%583.77M42.90%275.7M71.44%158.58M
Fair value change income 126.64%9.53M127.30%7.54M293.79%7.34M-176.15%-58.26M-2,111.84%-35.77M-271.47%-27.62M63.13%-3.79M111.14%76.5M96.46%-1.62M254.47%16.11M
Invest income -171.67%-31.42M-68.86%-16.14M-98.14%615.9K-112.69%-49.16M-110.77%-11.57M-117.08%-9.56M12.32%33.1M81.49%387.36M-36.09%107.41M-45.20%55.98M
-Including: Investment income associates -15.10%-54.23M17.77%-34.38M-----15.40%-72.7M---47.11M---41.8M-----807.71%-63M--------
Asset deal income -52.58%2.15M-22.72%2.02M26.53%1.62M-42.22%3.16M1,956.49%4.53M665.72%2.61M161.38%1.28M62.36%5.47M-92.81%220.44K-120.18%-460.98K
Other revenue 10.48%270.74M13.02%168.31M122.67%54.68M73.45%498.49M30.54%245.07M17.67%148.92M-39.00%24.56M-7.00%287.4M99.03%187.73M276.79%126.56M
Operating profit 35.62%5.35B55.04%3.98B21.69%1.64B19.41%4.91B7.93%3.94B7.15%2.57B-1.56%1.34B-11.85%4.11B-28.02%3.65B-25.67%2.4B
Add:Non operating Income 137.84%5.79M94.17%3.13M-53.56%198.81K82.46%3.8M73.51%2.43M70.07%1.61M17.45%428.07K-6.35%2.08M-54.21%1.4M-39.84%948.61K
Less:Non operating expense 101.19%264.34M297.98%236.31M564.84%133.7M69.42%246.59M10.18%131.39M24.45%59.38M2,876.16%20.11M-27.49%145.55M-19.04%119.24M-52.78%47.71M
Total profit 33.43%5.09B49.32%3.75B13.42%1.5B17.60%4.67B7.88%3.81B6.83%2.51B-2.98%1.32B-11.15%3.97B-28.30%3.53B-24.80%2.35B
Less:Income tax cost 30.18%470.41M45.68%323.47M47.80%135.02M153.86%389.29M-17.49%361.35M-21.76%222.04M-41.86%91.36M965.50%153.35M-40.57%437.95M-39.00%283.8M
Net profit 33.77%4.62B49.67%3.43B10.87%1.37B12.13%4.28B11.47%3.45B10.75%2.29B2.08%1.23B-14.92%3.82B-26.14%3.1B-22.32%2.07B
Net profit from continuing operation 33.77%4.62B49.67%3.43B10.87%1.37B12.13%4.28B11.47%3.45B10.75%2.29B2.08%1.23B-14.92%3.82B-26.14%3.1B-22.32%2.07B
Less:Minority Profit 85.73%-3.25M79.75%-3.62M74.79%-1.44M73.02%-24.62M70.59%-22.75M65.17%-17.86M80.07%-5.72M-97.51%-91.23M-405.50%-77.34M-886.91%-51.27M
Net profit of parent company owners 32.98%4.62B48.67%3.43B10.48%1.37B10.14%4.3B9.47%3.47B8.91%2.31B0.17%1.24B-13.77%3.91B-24.57%3.17B-20.55%2.12B
Earning per share
Basic earning per share 32.73%0.7350.00%0.5410.53%0.2111.48%0.6810.00%0.559.09%0.360.00%0.19-14.08%0.61-24.24%0.5-21.43%0.33
Diluted earning per share 32.73%0.7350.00%0.5410.53%0.2111.48%0.6810.00%0.559.09%0.360.00%0.19-14.08%0.61-24.24%0.5-21.43%0.33
Other composite income -190.19%-12.63M-100.08%-17.23K69.90%-5.93M12.43%17.84M311.21%14M659.72%22.51M-14,648.05%-19.69M302.41%15.87M-672.97%-6.63M-1,273.58%-4.02M
Other composite income of parent company owners -205.33%-11.5M-104.12%-772.84K66.49%-6.14M8.96%16.09M246.37%10.92M505.91%18.74M-72,524.52%-18.33M300.53%14.77M-948.39%-7.46M-12,147.55%-4.62M
Other composite income of minority owners -136.66%-1.13M-79.95%755.61K115.94%216.54K59.17%1.75M272.75%3.09M532.90%3.77M-1,155.38%-1.36M331.60%1.1M665.88%828.16K333.43%595.53K
Total composite income 32.86%4.6B48.22%3.43B12.18%1.36B12.13%4.3B12.16%3.47B12.06%2.31B0.46%1.21B-14.41%3.83B-26.29%3.09B-22.47%2.06B
Total composite income of parent company owners 32.24%4.61B47.44%3.43B11.63%1.36B10.13%4.32B10.07%3.48B10.04%2.33B-1.31%1.22B-13.30%3.92B-24.74%3.17B-20.72%2.11B
Total composite income of minority owners 77.74%-4.38M79.70%-2.86M82.70%-1.22M74.63%-22.87M74.30%-19.66M72.20%-14.09M75.43%-7.07M-93.16%-90.14M-395.35%-76.52M-829.79%-50.68M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Suya Jincheng Certified Public Accountants (Special General Partnership)------Suya Jincheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data